TP53 and Miyoshi myopathy: In our study, we have explored the association of the TP53 rs1042522 variant, expression levels of TP53 genotypes, deletion of TP53 locus and chromosome 17 aneuploidies with the risk of MM development, and response to bortezomib/thalidomide treatment in Caucasian population.